Brisbane-based medical device firm Oventus Medical has successfully listed on the stock exchange and raised $12 million towards the commercialisation and distribution of its new sleep apnoea device, a customisable mouthguard that is 3D-printed to the exact dimensions of the patient's mouth.

Formerly known as the Oventus Clearway device and now rebranded as the O2Vent, the device has been listed with Australia's Therapeutic Goods Administration and it received clearance from the US Food and Drug Administration (FDA) in April.